Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Mod Pathol. 2019 Jul 8;32(12):1806–1813. doi: 10.1038/s41379-019-0317-6

Table 3.

Comparison of histologic subtype between patients with germline ATM pathogenic variants and familial or sporadic pancreatic cancer patients

Histologic subtype Patients with germline ATM pathogenic variants (n = 23) Familial pancreatic cancer patients (n = 519) p-value Sporadic pancreatic cancer patients (n = 651) p-value
Colloid carcinoma, n (%)   3 (13)    4 (1) 0.002   10 (2) 0.008
Other (non-colloid) carcinoma, n (%) 20 (87) 515 (99) 621 (98)

Data for familial and sporadic pancreatic cancer patients from Singhi et al. [27]